S2M — S2Medical AB (publ) Cashflow Statement
0.000.00%
- SEK10.47m
- SEK9.46m
- SEK14.91m
Annual cashflow statement for S2Medical AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | SAS | SAS | SAS | SAS | — |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -15.1 | -19.8 | -27.7 | -15.3 | 5.78 |
Depreciation | |||||
Non-Cash Items | 0 | -0.018 | -0.102 | 0 | 0 |
Other Non-Cash Items | |||||
Changes in Working Capital | 0.774 | -1.3 | -2.26 | -2.99 | -10.5 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -13 | -19.7 | -28.1 | -16.5 | -3.67 |
Capital Expenditures | -1.98 | -3.1 | -1.9 | -1.15 | -0.634 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0 | 0.072 | 0.138 | 0 | 0 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Cash from Investing Activities | -1.98 | -3.02 | -1.76 | -1.15 | -0.634 |
Financing Cash Flow Items | -1.09 | -2.53 | -0.668 | -4.7 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 24.4 | 6.85 | 24.1 | 15.5 | 3.79 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 9.43 | -15.8 | -5.76 | -2.21 | -0.512 |